The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

30 May 2018 12:05

RNS Number : 7010P
Circassia Pharmaceuticals Plc
30 May 2018
 

30 May 2018

Circassia Pharmaceuticals plc

Result of Annual General Meeting 2018

Circassia Pharmaceuticals plc ("Circassia") announces that at its Annual General Meeting held today all resolutions set out in the notice of Annual General Meeting dated 24 April 2018 were passed. A poll was conducted on each resolution proposed at the Meeting and the number of votes cast for and against each of the resolutions, and the number of votes withheld, were as follows:

Resolution

For

%

Against

%

Withheld*

1

To receive the Annual report and accounts

285,133,907

100.00

0

0.00

995,178

2

To approve the Annual report on remuneration

223,906,652

79.49

57,766,863

20.51

4,455,570

3

To approve the Directors' remuneration policy report

285,086,229

99.64

1,042,856

0.36

0

4

To re-elect Francesco Granata

285,132,644

100.00

6,250

0.00

990,191

5

To re-elect Steve Harris

286,121,980

100.00

7,093

0.00

13

6

To re-elect Julien Cotta

286,124,073

100.00

5,000

0.00

13

7

To re-elect Rod Hafner

286,121,947

100.00

7,126

0.00

13

8

To re-elect Lota Zoth

285,438,397

99.76

690,676

0.24

13

9

To re-elect Russell Cummings

286,120,730

100.00

8,343

0.00

13

10

To elect Jo le Couilliard

286,121,790

100.00

7,283

0.00

13

11

To elect Sharon Curran

286,127,823

100.00

1,250

0.00

13

12

To elect Heribert Staudinger

286,120,730

100.00

8,343

0.00

13

13

To re-appoint PwC as auditors

285,114,185

99.65

1,011,900

0.35

3,000

14

To authorise the Audit Committee to determine the remuneration of the auditors

282,216,197

98.63

3,909,888

1.37

3,000

15

To authorise the directors to allot shares

286,121,325

100.00

7,250

0.00

511

16

To authorise the directors to dis-apply pre-emption rights**

286,114,199

100.00

9,376

0.00

5,511

17

To authorise the directors to dis-apply pre-emption rights in respect of an additional 5% of the Company's issued share capital**

 

285,104,437

99.64

1,019,137

0.36

5,511

18

To authorise the calling of general meetings (other than an AGM) on not less than 14 clear days' notice**

286,073,998

99.98

49,577

0.02

5,511

 

 

As explained in the notice of Annual General Meeting dated 24 April 2018, Circassia further announces the result of the vote of independent shareholders in respect of resolutions 8, and 10 to 12.

Resolution

For

%

Against

%

Withheld*

8

To re-elect Lota Zoth

25,509,089

97.36

690,676

2.64

13

10

To elect Jo le Couilliard

26,192,482

99.97

7,283

0.03

13

11

To elect Sharon Curran

26,198,515

100.00

1,250

0.00

13

12

To elect Heribert Staudinger

26,191,422

99.97

8,343

0.03

13

* A vote withheld is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

** Special resolution.

In accordance with LR 9.6.2, a copy of the resolutions passed at today's Annual General Meeting will be submitted to the National Storage Mechanism and will be shortly available for inspection at www.morningstar.co.uk/uk/NSM.

For enquiries, contact: Julien Cotta, Company Secretary +44 (0)1865 405560.

A copy of this announcement has been posted on the company's website, www.circassia.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSDLFFSFASESI
Date   Source Headline
8th Jul 20195:02 pmRNSHolding(s) in Company
5th Jul 201912:07 pmRNSHolding(s) in Company
2nd Jul 20195:56 pmRNSHolding(s) in Company
2nd Jul 20195:56 pmRNSHolding(s) in Company
2nd Jul 20195:55 pmRNSHolding(s) in Company
1st Jul 20194:55 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSTotal Voting Rights
25th Jun 20194:57 pmRNSBlock Listing Application
17th Jun 20194:35 pmRNSPrice Monitoring Extension
7th Jun 20196:00 pmRNSHolding(s) in Company
7th Jun 20194:18 pmRNSResult of AGM
6th Jun 20196:23 pmRNSHolding(s) in Company
6th Jun 20194:11 pmRNSHolding(s) in Company
31st May 20197:00 amRNSTotal Voting Rights
28th May 20195:58 pmRNSHolding(s) in Company
28th May 20195:56 pmRNSHolding(s) in Company
21st May 20199:05 amRNSHolding(s) in Company
14th May 20194:24 pmRNSAnnual report and notice of AGM
8th May 20197:00 amRNSPublication of Tudorza Phase IV ASCENT in JAMA
3rd May 20192:18 pmRNSIssue of Equity
1st May 20197:00 amRNSFinal Results
30th Apr 20197:00 amRNSTotal Voting Rights
15th Apr 201911:55 amRNSHolding(s) in Company
1st Apr 20197:00 amRNSFDA approval of Duaklir for treatment of COPD
29th Mar 20194:40 pmRNSSecond Price Monitoring Extn
29th Mar 20194:35 pmRNSPrice Monitoring Extension
29th Mar 20193:58 pmRNSFDA website posts Duaklir NDA approval
29th Mar 20193:34 pmRNSCircassia announces FDA approval of Tudorza sNDA
29th Mar 20197:00 amRNSTotal Voting Rights
5th Mar 20194:53 pmRNSHolding(s) in Company
4th Mar 20194:04 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSTotal Voting Rights
11th Feb 20195:17 pmRNSHolding(s) in Company
8th Feb 20199:00 amRNSNotice of Results
6th Feb 20194:44 pmRNSHolding(s) in Company
6th Feb 20197:00 amRNSHolding(s) in Company
4th Feb 20195:57 pmRNSHolding(s) in Company
4th Feb 20198:06 amRNSSuccessful FDA Presubmission Meeting for AirNOvent
4th Feb 20198:06 amRNSAdmission to AIM
1st Feb 20194:36 pmRNSPrice Monitoring Extension
1st Feb 20194:03 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTotal Voting Rights
30th Jan 20195:30 pmRNSCircassia Pharmaceuticals
30th Jan 20194:41 pmRNSSecond Price Monitoring Extn
30th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20193:30 pmRNSHolding(s) in Company
28th Jan 20193:30 pmRNSHolding(s) in Company
25th Jan 201911:49 amRNSHolding(s) in Company
24th Jan 20197:00 amRNSCommercial rights acquired from AIT Therapeutics
18th Jan 20192:22 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.